Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2012
  • Online publication date: September 2012

Chapter 5 - Modafinil reversal of cognitive deficits during sleep loss

from Section 2 - Stimulant Reversal of Cognitive Deficits


[1] SchwartzJR. Modafinil in the treatment of excessive sleepiness. Drug Des Devel Ther 2009; 2: 71–85.
[2] KumarR. Approved and investigational uses of modafinil : an evidence-based review. Drugs 2008; 68(13): 1803–39.
[3] WesenstenNJ. Effects of modafinil on cognitive performance and alertness during sleep deprivation. Current Pharmaceutical Design 2006; 12: 2457–71.
[4] BonnetMH, BalkinTJ, DingesDF, et al.; Sleep Deprivation and Stimulant Task Force of the American Academy of Sleep Medicine. The use of stimulants to modify performance during sleep loss: a review by the sleep deprivation and Stimulant Task Force of the American Academy of Sleep Medicine. Sleep 2005; 28(9): 1163–87.
[5] MinzenbergMJ, CarterCS. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 2008; 33(7): 1477–502.
[6] SaletuB, GrünbergerJ, LinzmayerL, StöhrH. Pharmaco-EEG, psychometric and plasma level studies with two novel alpha-adrenergic stimulants CRL 40472 and 40028 (Adrafinil) in elderlies. New Trends Exper Clin Psychiatr 1986; 2: 5–31
[7] SaletuB, FreyR, KrupkaM, et al. Differential effects of the new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behavior in elderlies. Arzneim-Forsch./Drug Res 1989; 39: 1268–73.
[8] SaletuB, FreyR, KrupkaM, et al. Differential effects of a new central adrenergic agonist – modafinil – and d-amphetamine on sleep and early morning behavior in young healthy volunteers. Int J Clin Pharm Res 1989; 13: 183–95.
[9] BenoitO, ClodoreM, TouronN, PailhousE. Effects of modafinil on sleepiness in normal sleep deprived and symptomatic subjects. Proceedings of the 5th International Congress of Sleep Research, Copenhagen, 1987, p. 135.
[10] BaranskiJV, CianC, EsquivieD, PigeauRA, RaphelC. Modafinil during 64 hr of sleep deprivation: dose-related effects on fatigue, alertness, and cognitive performance. Mil Psychol 1998; 10: 173–93.
[11] MoachonG, KanmacherI, ClenetM, MatinierD. Pharmacokinetic profile of modafinil. Drugs Today 1996; 32: 327–37.
[12] PigeauR, NaitohP, BuguetA, et al. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995; 4: 212–28.
[13] BaranskiJV, PigeauRA. Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. J Sleep Res 1997; 6: 84–91.
[14] WesenstenNJ, BelenkyG, KautzMA, et al. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl) 2002; 159: 238–47.
[15] DingesDF, PowellJW. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Meth Instr Comp 1985; 17: 652–5.
[16] BalkinTJ, BliesePD, BelenkyG, et al. Comparative utility of instruments for monitoring sleepiness-related performance decrements in the operational environment. J Sleep Res 2004; 13(3): 219–27.
[17] HartCL, HaneyM, VosburgSK, et al. Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology 2006; 31(7): 1526–36.
[18] BaranskiJV, GilV, McLellanTM, et al. Effects of modafinil on cognitive performance during 40 hours of sleep deprivation in a warm environment. Mil Psychol 2002; 14: 23–47.
[19] BodenmannS, XuS, LuhmannUF, et al. Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep. Clin Pharmacol Ther 2009; 85(3): 296–304.
[20] StivaletP, EsquivieD, BarraudP-A, LeifflenD, RaphelC. Effects of modafinil on attentional processes during 60 hours of sleep deprivation. Hum Psychopharmacol Clin Exp 1998; 13: 501–7.
[21] LagardeD, BatejatD. Disrupted sleep-wake rhythm and performance: advantages of modafinil. Military Psychology 1995; 7(3): 165–91.
[22] BatejatDM, LagardeDP. Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviat Space Environ Med 1999; 70: 493–8.
[23] CaldwellJA, CaldwellJL, SmytheNK, HallKK. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology (Berl) 2000; 150: 272–82.
[24] CaldwellJA, CaldwellJL, SmithJK, BrownDL. Modafinil’s effects on simulator performance and mood in pilots during 37 h without sleep. Aviat Space Environ Med 2004; 75: 777–85.
[25] BrunJ, ChambaG, KhalfallahY, et al. Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. J Sleep Res 1998; 7: 105–14.
[26] BensimonG, BenoitD, LacomblezL, et al. Antagonism by modafinil of the psychomotor and cognitive impairment induced by sleep-deprivation in 12 healthy volunteers. Eur Psychiatry 1991; 6: 93–7.
[27] BatéjatD, CosteO, Van BeersP, et al. Prior sleep with zolpidem enhances the effect of caffeine or modafinil during 18 hours continuous work. Aviat Space Environ Med 2006; 77(5): 515–25.
[28] DaganY, DoljanskyJT. Cognitive performance during sustained wakefulness: a low dose of caffeine is equally effective as modafinil in alleviating the nocturnal decline. Chronobiol Int 2006; 23(5): 973–83.
[29] GurtmanCG, BroadbearJH, RedmanJR. Effects of modafinil on simulator driving and self-assessment of driving following sleep deprivation. Hum Psychopharmacol 2008; 23(8): 681–92.
[30] ThomasRJ, KwongK. Modafinil activates cortical and subcortical sites in the sleep-deprived state. Sleep 2006; 29(11): 1471–81.
[31] GillM, HaerichP, WestcottK, GodenickKL, TuckerJA. Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study. Acad Emerg Med 2006; 13(2): 158–65. [Erratum in: Acad Emerg Med 2006; 13(4): 477]
[32] WesenstenN, KillgoreW, BalkinT. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res 2005; 14: 255–66.
[33] KillgoreWD, RuppTL, GrugleNL, et al. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. J Sleep Res 2008; 17(3): 309–21.
[34] WalshJK, RandazzoAC, StoneKL, SchweitzerPK. Modafinil improves alertness, vigilance, and executive function during simulated night shifts. Sleep 2004; 27: 434–9.
[35] ThomasM, SingH, BelenkyG, et al. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res 2000; 9: 335–52.
[36] GoelN, RaoH, DurmerJS, DingesDF. Neurocognitive consequences of sleep deprivation. Semin Neurol 2009; 29(4): 320–39.
[38] Coalition Investigation Board Report. Summary of Facts Tarnak Farms Friendly Fire Incident Near Kandahar, Afghanistan, 17 April 2002.
[39] KillgoreWD, McBrideSA, KillgoreDB, BalkinTJ. The effects of caffeine,dextroamphetamine, and modafinil on humor appreciation during sleep deprivation. Sleep 2006; 29(6): 841–7.
[40] HuckNO, McBrideSA, KendallAP, GrugleNL, KillgoreWD. The effects of modafinil, caffeine, and dextroamphetamine on judgments of simple versus complex emotional expressions following sleep deprivation. Int J Neurosci 2008; 118(4): 487–502.
[41] KillgoreWD, MuckleAE, GrugleNL, KillgoreDB, BalkinTJ. Sex differences in cognitive estimation during sleep deprivation: effects of stimulant countermeasures. Int J Neurosci 2008; 118(11): 1547–57.
[42] KillgoreWD, GrugleNL, KillgoreDB, et al. Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. Aviat Space Environ Med 2008; 79(9): 867–74.
[43] KillgoreWD, Kahn-GreeneET, GrugleNL, KillgoreDB, BalkinTJ. Sustaining executive functions during sleep deprivation: a comparison of caffeine, dextroamphetamine, and modafinil. Sleep 2009; 32(2): 205–16.
[44] BardEG, SotilloC, AndersonAH, ThompsonHS, TaylorMM. The DCIEM Map Task Corpus: spontaneous dialogue under sleep deprivation and drug treatment. Speech Commun 1996; 20: 71–84.
[45] PigeauRA, AngusRG. Modafinil and amphetamine versus naps in sustained operations. In: FriedlK, LiebermanH, RyanDH, BrayGA, editors. Countermeasures for Battlefield Stressors. Baton Rouge: Louisiana State University Press; 2000: 206–27.
[46] LandoltHP. Genotype-dependent differences in sleep, vigilance, and response to stimulants. Current Pharmaceutical Design 2008; 14: 3396–407.
[47] DijkDJ, ArcherSN. PERIOD3, circadian phenotypes, and sleep homeostasis. Sleep Med Rev 2010; 14: 151–60.
[48] GoelN, BanksS, MignotE, DingesDF. PER3 polymorphism predicts cumulative sleep homeostatic but not neurobehavioral changes to chronic partial sleep deprivation. PLoS One 2009; 4: e5874.
[49] GradyS, AeschbachD, WrightKP Jr, CzeislerCA. Effect of modafinil on impairments in neurobehavioral performance and learning associated with extended wakefulness and circadian misalignment. Neuropsychopharmacology 2010; 35(9): 1910–20.
[50] RandallDC, ShneersonJM, PlahaKK, FileSE. Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 2003; 18(3): 163–73.
[51] TurnerDC, RobbinsTW, ClarkL, et al. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 2003; 165(3): 260–9.
[52] BaranskiJV, PigeauR, DinichP, JacobsI. Effects of modafinil on cognitive and meta-cognitive performance. Hum Psychopharmacol 2004; 19(5): 323–32.
[53] MüllerU, SteffenhagenN, RegenthalR, BublakP. Effects of modafinil on working memory processes in humans. Psychopharmacology (Berl) 2004; 177(1–2): 161–9.
[54] RycroftN, HuttonSB, ClowryO, et al. Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison. Psychopharmacology (Berl) 2007; 195(2): 245–53.
[55] MakrisAP, RushCR, FrederichRC, TaylorAC, KellyTH. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Exp Clin Psychopharmacol 2007; 15(2): 123–33.
[56] DoddsC, MüllerU, ManlyT. Effects of psychostimulants on alertness and spatial bias in healthy participants. J Cogn Neurosci 2009; 21(3): 529–37.
[57] MinzenbergMJ, WatrousAJ, YoonJH, UrsuS, CarterCS. Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. Science 2008; 322(5908): 1700–2.
[58] JooEY, TaeWS, JungKY, HongSB. Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study. J Sleep Res 2008; 17(1): 82–8.
[59] MarchantNL, KamelF, EchlinK, et al. Modafinil improves rapid shifts of attention. Psychopharmacology (Berl) 2009; 202(1–3): 487–95.
[60] TheunissenEL, de la AsuncionElvira J, van den BerghD, RamaekersJG. Comparing the stimulant effects of the H1-antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate. J Clin Psychopharmacol 2009; 29: 439–43.
[61] Winder-RhodesSE, ChamberlainSR, IdrisMI, et al. Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers. J Psychopharmacol 2010; 24(11): 1649–57.